The Sands of Time Cannot be Stilled

Article

Special Issues

LCGC SupplementsSpecial Issues-07-01-2006
Volume 0
Issue 0

The FDA has been implementing several changes in the way it does business, for example, relying on third-party inspections, academia, and industry in many new ways. The implementation of process analytical technology is among these changes.

External Link - article-416321.pdf

Articles in this issue
Analytical Instrument Qualification
GMP and Phase I Clinical Trials: Streamlining the Critical Path?
GMP and Phase I Clinical Trials: Streamlining the Critical Path?
Team Effort
Team Effort
Rated PG: Pharmaceutical Guidance Suggested
Rated PG: Pharmaceutical Guidance Suggested
European Clinical Trial Regulations Undergo a Slow Revolution
European Clinical Trial Regulations Undergo a Slow Revolution
A Practical and Cost-Effective Risk Assessment for the Validation of Commercial Laboratory Computerized Systems
A Practical and Cost-Effective Risk Assessment for the Validation of Commercial Laboratory Computerized Systems
Moving Biotech Products from CBER to CDER: A Work in Progress
Moving Biotech Products from CBER to CDER: A Work in Progress
FDA Video Interview Conducted by Jill Wechsler, Washington Bureau Chief
New Climate
New Climate
2006: A Regulatory Odyssey
2006: A Regulatory Odyssey
CDER?s Division of Post-Marketing Evaluation for Quality Assessment
CDER?s Division of Post-Marketing Evaluation for Quality Assessment
Better Compliance Through Technology
Better Compliance Through Technology
Good Clinical Practice Q&A
Good Clinical Practice Q&A
Keeping Pace
Keeping Pace
The Growing Regulatory Burden and Revolution in Global Clinical Trials
The Growing Regulatory Burden and Revolution in Global Clinical Trials
Related Videos
Robert Kennedy
John McLean | Image Credit: © Aaron Acevedo
Related Content
lung cancer | Image Credit: © utah51 - stock.adobe.com

LC–MS/MS Array Created to Help Prognoses for Lung Cancer

April 16th 2024
Article

Scientists from the Netherlands created a new LC–MS/MS assay to test new small molecular inhibitors (SMIs) and their effectiveness in prognosing lung cancer.

Ep. 23: Color My World: The Complexities of Color Measurements

Ep. 23: Color My World: The Complexities of Color Measurements

April 1st 2024
Podcast
Site Logo

Merck KGaA, Darmstadt, Germany: Greener Sampling of Terpenes in Cannabis

April 16th 2024
Article

This application note demonstrates the use of Thermal Desorption as greener approach for sampling of terpenes in air for workplace exposure or terpene profiling

Ep. 22: Around the world with The Multidimensional Chromatography Workshop

Ep. 22: Around the world with The Multidimensional Chromatography Workshop

March 7th 2024
Podcast
Katarina Marakova of the Department of Pharmaceutical Analysis and Nuclear Pharmacy at Comenius University Bratislava. Photo Credit: © Katarina Marakova.

A Look at Capillary Zone Electrophoresis–Mass Spectrometry in Complex Biological Matrices: An Interview with Katarina Marakova

April 15th 2024
Article

LCGC International sat down with Katarina Marakova to discuss her group’s work in top-down analysis of proteins using capillary zone electrophoresis–mass spectrometry (CZE–MS).

Analytica 2024: An Interview with Michael Lämmerhofer

Analytica 2024: An Interview with Michael Lämmerhofer

April 15th 2024
Article

In this interview from Analytica 2024 in Munich, Germany, Michael Lämmerhofer of the University of Tuebingen discusses the potential of chiral stationary phases (CSPs) in different applications.